VRTX logo

VRTX Interest expense

annual interest expense:

$30.60M-$13.50M(-30.61%)
December 31, 2024

Summary

  • As of today (May 21, 2025), VRTX annual interest expense is $30.60 million, with the most recent change of -$13.50 million (-30.61%) on December 31, 2024.
  • During the last 3 years, VRTX annual interest expense has fallen by -$30.90 million (-50.24%).
  • VRTX annual interest expense is now -63.66% below its all-time high of $84.21 million, reached on December 31, 2015.

Performance

VRTX Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

quarterly interest expense:

$3.00M+$200.00K(+7.14%)
March 31, 2025

Summary

  • As of today (May 21, 2025), VRTX quarterly interest expense is $3.00 million, with the most recent change of +$200.00 thousand (+7.14%) on March 31, 2025.
  • Over the past year, VRTX quarterly interest expense has dropped by -$7.40 million (-71.15%).
  • VRTX quarterly interest expense is now -87.65% below its all-time high of $24.30 million, reached on December 31, 2017.

Performance

VRTX quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

TTM interest expense:

$23.20M-$7.40M(-24.18%)
March 31, 2025

Summary

  • As of today (May 21, 2025), VRTX TTM interest expense is $23.20 million, with the most recent change of -$7.40 million (-24.18%) on March 31, 2025.
  • Over the past year, VRTX TTM interest expense has dropped by -$19.90 million (-46.17%).
  • VRTX TTM interest expense is now -72.62% below its all-time high of $84.73 million, reached on September 30, 2015.

Performance

VRTX TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRTXincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

VRTX Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.6%-71.2%-46.2%
3 y3 years-50.2%-79.9%-61.8%
5 y5 years-47.7%-78.8%-59.8%

VRTX Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-50.2%at low-79.9%+7.1%-61.8%at low
5 y5-year-50.2%at low-81.6%+7.1%-63.0%at low
alltimeall time-63.7%+132.0%-87.7%+3057.9%-72.6%+586.8%

VRTX Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.00M(+7.1%)
$23.20M(-24.2%)
Dec 2024
$30.60M(-30.6%)
$2.80M(-62.7%)
$30.60M(-20.3%)
Sep 2024
-
$7.50M(-24.2%)
$38.40M(-8.1%)
Jun 2024
-
$9.90M(-4.8%)
$41.80M(-3.0%)
Mar 2024
-
$10.40M(-1.9%)
$43.10M(-2.3%)
Dec 2023
$44.10M(-19.5%)
$10.60M(-2.8%)
$44.10M(-2.2%)
Sep 2023
-
$10.90M(-2.7%)
$45.10M(-5.8%)
Jun 2023
-
$11.20M(-1.8%)
$47.90M(-6.6%)
Mar 2023
-
$11.40M(-1.7%)
$51.30M(-6.4%)
Dec 2022
$54.80M(-10.9%)
$11.60M(-15.3%)
$54.80M(-6.0%)
Sep 2022
-
$13.70M(-6.2%)
$58.30M(-2.5%)
Jun 2022
-
$14.60M(-2.0%)
$59.80M(-1.5%)
Mar 2022
-
$14.90M(-1.3%)
$60.70M(-1.3%)
Dec 2021
$61.50M(+5.7%)
$15.10M(-0.7%)
$61.50M(-2.0%)
Sep 2021
-
$15.20M(-1.9%)
$62.74M(+2.2%)
Jun 2021
-
$15.50M(-1.3%)
$61.39M(+2.7%)
Mar 2021
-
$15.70M(-3.9%)
$59.76M(+2.7%)
Dec 2020
$58.20M(-0.5%)
$16.34M(+17.9%)
$58.20M(+3.7%)
Sep 2020
-
$13.86M(-0.1%)
$56.11M(-1.2%)
Jun 2020
-
$13.87M(-1.9%)
$56.80M(-1.7%)
Mar 2020
-
$14.14M(-0.8%)
$57.77M(-1.3%)
Dec 2019
$58.50M(-19.3%)
$14.25M(-2.1%)
$58.50M(-7.1%)
Sep 2019
-
$14.55M(-1.9%)
$63.00M(-6.2%)
Jun 2019
-
$14.84M(-0.2%)
$67.14M(-4.7%)
Mar 2019
-
$14.87M(-20.7%)
$70.45M(-2.8%)
Dec 2018
$72.47M(+4.6%)
$18.74M(+0.3%)
$72.47M(-7.1%)
Sep 2018
-
$18.69M(+2.9%)
$78.02M(+7.0%)
Jun 2018
-
$18.16M(+7.5%)
$72.91M(+5.0%)
Mar 2018
-
$16.89M(-30.5%)
$69.42M(+0.2%)
Dec 2017
$69.30M
$24.30M(+79.0%)
$69.30M(+5.9%)
Sep 2017
-
$13.57M(-7.4%)
$65.44M(-9.1%)
Jun 2017
-
$14.66M(-12.5%)
$72.01M(-7.1%)
DateAnnualQuarterlyTTM
Mar 2017
-
$16.77M(-18.0%)
$77.50M(-4.8%)
Dec 2016
$81.43M(-3.3%)
$20.44M(+1.5%)
$81.43M(-0.3%)
Sep 2016
-
$20.14M(-0.1%)
$81.65M(-1.2%)
Jun 2016
-
$20.16M(-2.6%)
$82.64M(-1.1%)
Mar 2016
-
$20.70M(+0.2%)
$83.60M(-0.7%)
Dec 2015
$84.21M(+15.6%)
$20.65M(-2.3%)
$84.21M(-0.6%)
Sep 2015
-
$21.13M(+0.1%)
$84.73M(+0.9%)
Jun 2015
-
$21.11M(-0.9%)
$83.98M(+7.0%)
Mar 2015
-
$21.31M(+0.6%)
$78.45M(+7.7%)
Dec 2014
$72.86M(+217.8%)
$21.18M(+3.9%)
$72.86M(+13.0%)
Sep 2014
-
$20.38M(+30.8%)
$64.50M(+45.9%)
Jun 2014
-
$15.59M(-0.8%)
$44.21M(+25.7%)
Mar 2014
-
$15.72M(+22.6%)
$35.18M(+53.4%)
Dec 2013
$22.93M(+52.4%)
$12.82M(>+9900.0%)
$22.93M(+126.8%)
Sep 2013
-
$95.00K(-98.5%)
$10.11M(+0.9%)
Jun 2013
-
$6.55M(+89.1%)
$10.02M(+189.1%)
Mar 2013
-
$3.46M(-15.5%)
$3.46M(-88.4%)
Dec 2012
$15.04M(-60.1%)
-
-
Mar 2012
-
$4.10M(-64.8%)
$29.78M(-21.0%)
Dec 2011
$37.68M(+95.5%)
$11.66M(+65.2%)
$37.68M(+11.8%)
Sep 2011
-
$7.06M(+1.4%)
$33.71M(+10.2%)
Jun 2011
-
$6.96M(-42.0%)
$30.60M(+12.0%)
Mar 2011
-
$12.00M(+56.1%)
$27.32M(+41.7%)
Dec 2010
$19.27M(+46.1%)
$7.69M(+94.5%)
$19.27M(+19.3%)
Sep 2010
-
$3.95M(+7.3%)
$16.15M(+14.3%)
Jun 2010
-
$3.68M(-6.9%)
$14.13M(+2.6%)
Mar 2010
-
$3.96M(-13.3%)
$13.77M(+4.4%)
Dec 2009
$13.19M(-2.1%)
$4.56M(+136.7%)
$13.19M(+52.9%)
Sep 2009
-
$1.93M(-42.0%)
$8.63M(+28.7%)
Jun 2009
-
$3.33M(-1.6%)
$6.70M(+98.4%)
Mar 2009
-
$3.38M
$3.38M
Dec 2008
$13.47M
-
-

FAQ

  • What is Vertex Pharmaceuticals Incorporated annual interest expense?
  • What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated quarterly interest expense?
  • What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
  • What is Vertex Pharmaceuticals Incorporated TTM interest expense?
  • What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?
  • What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?

What is Vertex Pharmaceuticals Incorporated annual interest expense?

The current annual interest expense of VRTX is $30.60M

What is the all time high annual interest expense for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high annual interest expense is $84.21M

What is Vertex Pharmaceuticals Incorporated annual interest expense year-on-year change?

Over the past year, VRTX annual interest expense has changed by -$13.50M (-30.61%)

What is Vertex Pharmaceuticals Incorporated quarterly interest expense?

The current quarterly interest expense of VRTX is $3.00M

What is the all time high quarterly interest expense for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high quarterly interest expense is $24.30M

What is Vertex Pharmaceuticals Incorporated quarterly interest expense year-on-year change?

Over the past year, VRTX quarterly interest expense has changed by -$7.40M (-71.15%)

What is Vertex Pharmaceuticals Incorporated TTM interest expense?

The current TTM interest expense of VRTX is $23.20M

What is the all time high TTM interest expense for Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated all-time high TTM interest expense is $84.73M

What is Vertex Pharmaceuticals Incorporated TTM interest expense year-on-year change?

Over the past year, VRTX TTM interest expense has changed by -$19.90M (-46.17%)
On this page